Amexdrug Corporation, through its wholly owned subsidiaries, operates as a pharmaceutical and cosmeceutical company.
The company specializes in the research and development, manufacture, and distribution of pharmaceutical drugs and cosmetics. Its activities also include distribution of prescription and over-the-counter drugs, private manufacturing and labeling, and a quality control laboratory. The company markets 14 products under the Sponix name.
The company’s wholly owned subsidiaries inclu...
Amexdrug Corporation, through its wholly owned subsidiaries, operates as a pharmaceutical and cosmeceutical company.
The company specializes in the research and development, manufacture, and distribution of pharmaceutical drugs and cosmetics. Its activities also include distribution of prescription and over-the-counter drugs, private manufacturing and labeling, and a quality control laboratory. The company markets 14 products under the Sponix name.
The company’s wholly owned subsidiaries include BioRx Pharmaceuticals, Inc.; Allied Med, Inc.; Dermagen, Inc.; and Royal Health Care, Inc.
BioRx Pharmaceuticals, Inc.
BioRx Pharmaceuticals, Inc. is a wholesale manufacturer of cost saving pharmacy supplies, prescription packaging and skin care, hair and nail care products. BioRx Pharmaceuticals, Inc. manufactures, markets, and distributes products to wholesalers, distributors and independent pharmacies. The focus and mission of BioRx Pharmaceuticals, Inc. is to create, develop, manufacture and distribute products to help ease pain and restore and maintain the overall well-being of its customers. BioRx Pharmaceuticals, Inc. is planning to sell these products to national chain drugstores, sport chain stores, natural food markets and other mass markets. These products would be marketed under the name of Sponix, and are being sold under the name of BioRx Pharmaceuticals.
Allied Med, Inc.
Allied Med, Inc. sells a line of brand name and generic pharmaceutical products, over-the-counter drug and non-drug products and health and beauty products to independent pharmacies, other retailers, alternative care facilities, and other wholesalers.
Dermagen, Inc.
Dermagen, Inc. is a manufacturing company specializing in the manufacturing and distribution of certain pharmaceuticals, medical devices, health and beauty products, and pharmacy and laboratory supplies. Dermagen, Inc. has a U.S.-Federal Drug Administration (FDA) registered and state FDA approved manufacturing facility licensed to develop high margin skin and novel health and beauty products for niche markets.
Royal Health Care Company
Royal Health Care Company is a health and beauty company, which has sold specially manufactured facial and body creams, arthritic pain relief medications and an exclusive patented hair care product to pharmacies, beauty salons, beauty supply stores and other fine shops. Royal Health Care Company products are manufactured by Dermagen, Inc. in an FDA approved manufacturing facility. Royal Health Care, Inc. manufactures and sells health and beauty products.
Segments
The company’s segments include Distribution and Health and Beauty Products.
Distribution consists of the wholesale pharmaceutical distribution and resale of brand and generic pharmaceutical products, over-the-counter drugs and non-drug products and health and beauty products.
Health and Beauty Products consist of the manufacture and distribution of primarily health and beauty products, and also pharmacy and laboratory supplies. Manufacturing includes expertise in research and development for the healthcare industry, including pharmacy and laboratory supplies.
Strategy
The company plans to market its name, products and services to create brand recognition and generate and capture traffic on its Websites; provide quality products at competitive prices and efficient service; and develop strategic relationships that increase its product offerings.
Sales and Marketing
The company’s products are sold both through traditional wholesale distribution lines and e-commerce venues, including its Website, www.amwrx.com. The company offers its products to small-sized pharmacy chains, alternative care facilities and other wholesalers and retailers in the state of California.
Government Regulations and Legal Uncertainties
Healthcare Regulation
The manufacturing, packaging, labeling, advertising, promotion, distribution and sale of most of the products the company distributes are subject to regulation by various governmental agencies, particularly the United States Food and Drug Administration, which regulates most of the products it distributes under the Federal Food, Drug and Cosmetic Act, and the United States Federal Trade Commission, which regulates the advertising of many of the products it distributes under the Federal Trade Commission Act. The products the company distributes are also subject to regulation by, among other regulatory agencies, the Consumer Product Safety Commission, the United States Department of Agriculture, the United States Department of Environmental Regulation, and the Occupational Safety and Health Administration. The manufacturing, labeling and advertising of the products the company distributes is also regulated by the Occupational Safety and Health Administration through various state and local agencies.
The company's advertising of dietary supplement products is also subject to regulation by the Federal Trade Commission under the Federal Trade Commission Act, in addition to state and local regulation. The Federal Trade Commission Act prohibits unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce. The Federal Trade Commission Act also provides that the dissemination or the causing to be disseminated of any false advertisement pertaining to drugs or foods, which would include dietary supplements, is an unfair or deceptive act or practice.
History
The company was founded in 1963. The company was incorporated under the laws of the state of California in 1963 under the name Harlyn Products, Inc. It changed its name to Amexdrug Corporation in 2000.